This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Feb;185(2):204-7.

doi: 10.1016/j.expneurol.2003.10.009.

SUMO, a ubiquitin-like modifier implicated in neurodegeneration

Andrew P Lieberman¹

Affiliations

PMID: 14736501
DOI: 10.1016/j.expneurol.2003.10.009

Review

SUMO, a ubiquitin-like modifier implicated in neurodegeneration

Andrew P Lieberman. Exp Neurol. 2004 Feb.

. 2004 Feb;185(2):204-7.

doi: 10.1016/j.expneurol.2003.10.009.

Author

Andrew P Lieberman¹

Affiliation

¹ Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. liebermn@umich.edu

PMID: 14736501
DOI: 10.1016/j.expneurol.2003.10.009

No abstract available

PubMed Disclaimer

Comment on

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease.
Pountney DL, Huang Y, Burns RJ, Haan E, Thompson PD, Blumbergs PC, Gai WP. Pountney DL, et al. Exp Neurol. 2003 Nov;184(1):436-46. doi: 10.1016/j.expneurol.2003.07.004. Exp Neurol. 2003. PMID: 14637113

Similar articles

SUMO on the road to neurodegeneration.
Dorval V, Fraser PE. Dorval V, et al. Biochim Biophys Acta. 2007 Jun;1773(6):694-706. doi: 10.1016/j.bbamcr.2007.03.017. Epub 2007 Mar 30. Biochim Biophys Acta. 2007. PMID: 17475350 Review.
SUMOylation in Neurodegenerative Diseases.
Princz A, Tavernarakis N. Princz A, et al. Gerontology. 2020;66(2):122-130. doi: 10.1159/000502142. Epub 2019 Sep 10. Gerontology. 2020. PMID: 31505513 Review.
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia.
Silveirinha V, Stephens GJ, Cimarosti H. Silveirinha V, et al. J Neurochem. 2013 Dec;127(5):580-91. doi: 10.1111/jnc.12347. Epub 2013 Jul 19. J Neurochem. 2013. PMID: 23786482 Review.
SUMO and its role in human diseases.
Sarge KD, Park-Sarge OK. Sarge KD, et al. Int Rev Cell Mol Biol. 2011;288:167-83. doi: 10.1016/B978-0-12-386041-5.00004-2. Int Rev Cell Mol Biol. 2011. PMID: 21482412 Review.
[SUMO, small but strong].
Debry JM. Debry JM. Med Sci (Paris). 2008 Oct;24(10):801-2. doi: 10.1051/medsci/20082410801. Med Sci (Paris). 2008. PMID: 18950572 French. No abstract available.

See all similar articles

Cited by

Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration.
Fu J, Yu HM, Chiu SY, Mirando AJ, Maruyama EO, Cheng JG, Hsu W. Fu J, et al. PLoS Genet. 2014 Oct 9;10(10):e1004579. doi: 10.1371/journal.pgen.1004579. eCollection 2014 Oct. PLoS Genet. 2014. PMID: 25299344 Free PMC article.
Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2.
Foran E, Bogush A, Goffredo M, Roncaglia P, Gustincich S, Pasinelli P, Trotti D. Foran E, et al. Glia. 2011 Nov;59(11):1719-31. doi: 10.1002/glia.21218. Epub 2011 Jul 18. Glia. 2011. PMID: 21769946 Free PMC article.
Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation.
Mukherjee S, Thomas M, Dadgar N, Lieberman AP, Iñiguez-Lluhí JA. Mukherjee S, et al. J Biol Chem. 2009 Aug 7;284(32):21296-306. doi: 10.1074/jbc.M109.011494. Epub 2009 Jun 4. J Biol Chem. 2009. PMID: 19497852 Free PMC article.
Characterization of a new SUMO-1 nuclear body (SNB) enriched in pCREB, CBP, c-Jun in neuron-like UR61 cells.
Navascués J, Bengoechea R, Tapia O, Vaqué JP, Lafarga M, Berciano MT. Navascués J, et al. Chromosoma. 2007 Oct;116(5):441-51. doi: 10.1007/s00412-007-0107-7. Epub 2007 May 26. Chromosoma. 2007. PMID: 17549507

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

NS044047/NS/NINDS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information